Nemolizumab Benefits for Atopic Dermatitis Maintained in Long-Term Follow-Up StudyNovember 12, 2024DermatologyAdolescent Medicine
Lichen Planus Responds to Treatment with Topical Ruxolitinib in Phase 2 StudyNovember 12, 2024Dermatology
Study Finds No Increased MACE Risk for JAK Inhibitors in Patients With Atopic DermatitisNovember 12, 2024DermatologyCardiology
Pemphigus, Bullous Pemphigoid Risk Increased After COVID-19 InfectionNovember 11, 2024VaccinesInfectious DiseasesCOVID-19 UpdatesDermatology
Scurvy: A Diagnosis Still Relevant TodayNovember 8, 2024GastroenterologyRare DiseasesDermatologyAnemiaHematologyRheumatologyNeurology
Cosmetic Dermatology Product Recalls Still Common, Analysis FindsNovember 4, 2024DermatologyMixed Topics
Novel Treatment Promising for Cutaneous Lupus in Phase 2 TrialNovember 4, 2024DermatologyRheumatology
Atopic Dermatitis: Upadacitinib Effectiveness Maintained Through 76 weeks Among AdolescentsOctober 28, 2024DermatologyAdolescent Medicine
